GENEVA, Aug. 31 -- ANBOGEN THERAPEUTICS USA, INC. filed a patent application (US2026/016292) for “PHARMACEUTICAL COMBINATION AND USES THEREOF”. With publication no. WO/2026/178511, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4045
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....